[Clinical treatment of diffuse unilateral subacute neuroretinitis with albendazole].

PURPOSE To describe the evolution of a series of cases of diffuse unilateral subacute neuroretinitis (DUSN) treated with albendazole. METHODS Interventional case series. The authors developed a non-randomized clinical trial protocol to investigate the clinical evolution of diffuse unilateral subacute neuroretinitis cases treated with albendazole. According to protocol criteria up to now, six patients were selected that will be described separately. RESULTS Of the six studied patients, four presented the worm. All six patients treated with the antiparasitic drug showed improvement of visual acuity and of chorioretinal scars. During the weeks of treatment, evidence of worm inactivation was documented for the four patients with visible worms. No adverse drug side effects were observed. CONCLUSIONS The antiparasitic drug albendazole seems to be beneficial and safe in patients with diffuse unilateral subacute neuroretinitis. More studies are necessary to evaluate the effectiveness of albendazole in the treatment of diffuse unilateral subacute neuroretinitis.

[1]  Rafael Cortez,et al.  Diffuse unilateral subacute neuroretinitis in Venezuela. , 2005, Ophthalmology.

[2]  Y. Nakashima,et al.  Clinical features and outcomes of patients with diffuse unilateral subacute neuroretinitis treated with oral albendazole. , 2005, American journal of ophthalmology.

[3]  W. Murray,et al.  Raccoon roundworm encephalitis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  C. A. G. Filho,et al.  Early-stage diffuse unilateral subacute neuroretinitis: improvement of vision after photocoagulation of the worm , 2004, Eye.

[5]  A. T. Davis,et al.  Eye findings of diffuse unilateral subacute neuroretinitis and multiple choroidal infiltrates associated with neural larva migrans due to Bbaylisascaris procyonis. , 2003, American journal of ophthalmology.

[6]  N. Khandelwal,et al.  One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial , 2003, The Pediatric infectious disease journal.

[7]  H. Furuoka,et al.  Diffuse Retinochoroiditis due to Baylisascaris procyonis in Monglian Gerbils , 2003, The Journal of parasitology.

[8]  C. Baumal,et al.  Multifocal electroretinography response after laser photocoagulation of a subretinal nematode. , 2002, American journal of ophthalmology.

[9]  R. Costa,et al.  Seria o Ancylostoma caninum um dos agentes da neurorretinite sub-aguda difusa unilateral (D.U.S.N.) no Brasil? , 2001 .

[10]  Gorbunov Av,et al.  Clinical course of isolated larval infestation of orbit in children , 2000 .

[11]  A. Gorbunov,et al.  [Clinical course of isolated larval infestation of orbit in children]. , 2000, Vestnik oftalmologii.

[12]  J. Gass,et al.  Diffuse bilateral subacute neuroretinitis: first patient with documented nematodes in both eyes. , 1999, Archives of ophthalmology.

[13]  J. Menezo,et al.  Diffuse Unilateral Subacute Neuroretinitis in Europe , 1999, European journal of ophthalmology.

[14]  R. Belfort,et al.  Antihelminthic drugs in diffuse unilateral subacute neuroretinitis. , 1998, American journal of ophthalmology.

[15]  D. Bundy,et al.  Anthelmintics. A comparative review of their clinical pharmacology. , 1997, Drugs.

[16]  D. Bundy,et al.  Anthelmintics: a review of their comparative clinical pharmacology , 1997 .

[17]  Y. Nakashima,et al.  Diffuse unilateral subacute neuroretinitis. Report of transvitreal surgical removal of a subretinal nematode. , 1995, Ophthalmology.

[18]  M. E. Farah,et al.  Neurorretinite subaguda unilateral difusa: 3 casos no Estado do Paraná , 1994 .

[19]  J. Gass,et al.  Oral therapy in diffuse unilateral subacute neuroretinitis. , 1992, Archives of ophthalmology.

[20]  S. Cunha,et al.  Neurorretinite subaguda unilateral difusa no Brasil: encontro da larva sub-retiniana , 1992 .

[21]  M. T. Medina,et al.  Plasma and CSF levels of albendazole and praziquantel in patients with neurocysticercosis. , 1990, Clinical neuropharmacology.

[22]  J. Gass,et al.  Further observations concerning the diffuse unilateral subacute neuroretinitis syndrome. , 1983, Archives of ophthalmology.